Tocilizumab
Form: Injection
Strength: 162 mg
Reference Brands:
Category: Osteoporosis
PJIA and SJIA are inflammatory diseases that causes pain and swelling in one or more joints in children aged 2 years and above. Actemra 162mg Injection reduces the symptoms like pain and swelling of the joints and also improves your performance in daily activities. It slows down the damage to the cartilage and bone of the joints that occurs due to arthritis.
Get Enquiry
Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Denosumab
Strength: 60 mg/mL, 120 mg/1.7 mL
Form: Injection
Reference Brands: Prolia, Xgeva
View Details
Zoledronic Acid
Strength: 5 mg/100 mL, 4 mg/5 mL (reconstituted)
Form: Injection
Reference Brands: Reclast, Zometa,Aclasta,
View DetailsCalcium Citrate + Alfacalcidol + Zinc Sulphate Tablet
Strength: 1000mg + 0.25mcg + 7.5mg
Form: Tablets
Reference Brands:
View Details